WHY BIOVIVA PLATFORM
BioViva’s core gene therapy technology is the subject of a pending patent application. Among other things, this includes aspects of the fundamental recombinant viral vectors and treatment methods that have been shown to significantly increase longevity, prevent age-related hair loss, increase blood glucose tolerance, increase physical coordination, reduce age-related weight loss, and reverse signs of mitochondrial dysfunction
Loading
Loading
Error